Altered metabolic states, for example in obesity, result in decreased insulin sensitivity in the skeletal muscle, liver, and adipose tissues that is counteracted by a compensatory increase in insulin secretion by β cells through an increase in both β cell function and mass [120]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.